Inventor

Bruce T. Liang

Inventor
Avon, CT, US

Overview

17→
Patents
1998–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium18%
C07KPeptides12%
C07HSugars9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
11,130,820Chimeric antigen receptors202110,695,355Methods for pharmacologic treatment of stroke20209,526,739'Compositions and methods to treat cardiac diseases'20169,303,053'Compositions and methods to treat cardiac diseases'20168,841,084'Methods for the detection and monitoring of acute myocardial infarction'20148,822,434'Compositions and methods to treat cardiac diseases'20148,410,078'Composition and methods to treat cardiac diseases'20137,998,690'Methods for the detection and monitoring of congestive heart failure'20117,867,983'Methods to protect skeletal muscle against injury'20117,745,150'Methods for the detection and monitoring of congestive heart failure'20107,348,315'Methods of treating heart failure with modified ATP, ADP and AMP compounds'20086,586,413'Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists'20036,329,349'Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents'20016,255,292'Purine nucleotide analogues, pharmaceutical compositions thereof, and methods of improving cardiac functions'20016,211,165'Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists'20015,859,019'Methods for protecting against cardiac ischemia by administering adenosine A.sub.2a receptor antagonists'19995,712,258'Inotropic ADP and ATP analogues and their pharmaceutical compositions'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2003Patents assigned to UNIV PENNSYLVANIA (6)· patent assignee history
1998–2003Based in Merion Station, PA, US· patent location history
2001–2020Patents assigned to US HEALTH (7)· patent assignee history
2008–2020Patents assigned to UNIV CONNECTICUT (10)· patent assignee history
2008Based in Marion, PA, US· patent location history
2010–2020Based in Avon, CT, US· patent location history
2014Patents assigned to AZRIN MICHAEL (1)· patent assignee history
2021Patents assigned to CELGENE CORP (1)· patent assignee history
2021Based in Closter, NJ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV CONNECTICUT102008–2020
US HEALTH72001–2020
UNIV PENNSYLVANIA61998–2003
AZRIN MICHAEL12014
CELGENE CORP12021
Locations
LocationPatentsSpan
Avon, CT, US92010–2020
Merion Station, Pennsylvania, US61998–2003
Closter, New Jersey, US12021
Marion, Pennsylvania, US12008